Search research articles
Contact Us
Filters
Showing results (1-10 of 40) with videos related to
Page
of 4
Sort By:
Pharmacology & Therapeutics
|
July 22, 2020
Targeting BET bromodomain proteins in cancer: The example of lymphomas
Filippo Spriano, Anastasios Stathis, Francesco Bertoni
Exploration of Targeted Anti-Tumor Therapy
|
January 19, 2023
Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences
Marilia Barreca, Noémie Lang, Chiara Tarantelli, et al.
Ejhaem
|
June 8, 2026
Antimicrobial Peptides Induce Cell Death in Marginal Zone Lymphoma Models Resistant to Targeted Therapies
Filippo Spriano, Alberto J Arribas, Fangwen Zhang, et al.
Oncotarget
|
February 25, 2016
Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy
Francesca Ricci, Maddalena Fratelli, Federica Guffanti, et al.
Chembiochem : a European Journal of Chemical Biology
|
September 11, 2025
Screening the Irish Marine Biorepository Identifies a New Bryostatin Analog as Potent Inhibitor of Activated B-Cells Diffuse Large B-Cell Lymphoma
Laurence K Jennings, Filippo Spriano, Maggie M Reddy, et al.
Molecular Cancer Therapeutics
|
May 9, 2019
DNA Damage Response Inhibitor Combinations Exert Synergistic Antitumor Activity in Aggressive B-Cell Lymphomas
Valentina Restelli, Monica Lupi, Rosaria Chilà, et al.
Chemmedchem
|
April 1, 2025
Development of C646-Based Proteolysis Targeting Chimeras Degraders of the Lysine Acetyltransferases CBP and p300
Francesco Fiorentino, Filippo Spriano, Daniela Tomaselli, et al.
Journal of Clinical Medicine
|
January 21, 2023
Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors
Francesca Guidetti, Alberto J Arribas, Giulio Sartori, et al.
Cancer Medicine
|
May 14, 2026
Exploring Resistance to ETS Targeting Agents in Diffuse Large B-Cell Lymphoma
Filippo Spriano, Luciano Cascione, Chiara Tarantelli, et al.
American Journal of Cancer Research
|
June 9, 2023
The microtubule-targeted agent lisavanbulin (BAL101553) shows anti-tumor activity in lymphoma models
Filippo Spriano, Luca Aresu, Luciano Cascione, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 40) with videos related to
Sort By:
Page
of 4
Pharmacology & Therapeutics
|
July 22, 2020
Targeting BET bromodomain proteins in cancer: The example of lymphomas
Filippo Spriano, Anastasios Stathis, Francesco Bertoni
Exploration of Targeted Anti-Tumor Therapy
|
January 19, 2023
Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences
Marilia Barreca, Noémie Lang, Chiara Tarantelli, et al.
Ejhaem
|
June 8, 2026
Antimicrobial Peptides Induce Cell Death in Marginal Zone Lymphoma Models Resistant to Targeted Therapies
Filippo Spriano, Alberto J Arribas, Fangwen Zhang, et al.
Oncotarget
|
February 25, 2016
Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy
Francesca Ricci, Maddalena Fratelli, Federica Guffanti, et al.
Chembiochem : a European Journal of Chemical Biology
|
September 11, 2025
Screening the Irish Marine Biorepository Identifies a New Bryostatin Analog as Potent Inhibitor of Activated B-Cells Diffuse Large B-Cell Lymphoma
Laurence K Jennings, Filippo Spriano, Maggie M Reddy, et al.
Molecular Cancer Therapeutics
|
May 9, 2019
DNA Damage Response Inhibitor Combinations Exert Synergistic Antitumor Activity in Aggressive B-Cell Lymphomas
Valentina Restelli, Monica Lupi, Rosaria Chilà, et al.
Chemmedchem
|
April 1, 2025
Development of C646-Based Proteolysis Targeting Chimeras Degraders of the Lysine Acetyltransferases CBP and p300
Francesco Fiorentino, Filippo Spriano, Daniela Tomaselli, et al.
Journal of Clinical Medicine
|
January 21, 2023
Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors
Francesca Guidetti, Alberto J Arribas, Giulio Sartori, et al.
Cancer Medicine
|
May 14, 2026
Exploring Resistance to ETS Targeting Agents in Diffuse Large B-Cell Lymphoma
Filippo Spriano, Luciano Cascione, Chiara Tarantelli, et al.
American Journal of Cancer Research
|
June 9, 2023
The microtubule-targeted agent lisavanbulin (BAL101553) shows anti-tumor activity in lymphoma models
Filippo Spriano, Luca Aresu, Luciano Cascione, et al.
Page
of 4